T gel vs. injections: what actually drives absorption failures

What's this video probably claiming?

Based on the caption, this creator switched from testosterone gel back to injections after roughly 18 months of subtherapeutic levels on gel, including the return of menstrual cycles. That's a real clinical problem, not a preference story. The video is almost certainly covering why gel didn't work for them, what symptoms signaled inadequate absorption, and why injections are now doing what gel couldn't. There's probably some framing around gel being a more "natural" or convenient option that ultimately failed them. Creators in this space often discuss wanting to retry gel after optimizing other variables, which the truncated caption hints at. The underlying claim being set up is that topical testosterone delivery is less reliable than injections, particularly for trans masculine individuals and others with hypogonadism who need consistent, measurable serum levels to suppress unwanted hormonal activity. That claim has genuine clinical backing, with important nuance.

What does the science actually show?

Topical testosterone gels produce highly variable serum levels across individuals. A 2011 study by Olson et al. in the Journal of Clinical Endocrinology and Metabolism documented interindividual variability in absorption reaching as high as 40-50% for the same nominal dose, driven by skin thickness, application site, hydration, and body surface area. For trans masculine individuals specifically, Singh et al. (2021, Andrology) found that testosterone cypionate injections produced more predictable suppression of LH and FSH, which directly correlates with menstrual cessation. Gel formulations like AndroGel 1.62% and Testim require skin contact time of at least 2 hours before showering, and transfer contamination is a real issue. For people needing levels consistently above 400-600 ng/dL to suppress menstruation, injections typically deliver more reliably. That doesn't make gel useless, it makes patient selection and monitoring more important than the delivery method itself.

Where does the social media noise diverge from clinical reality?

The loudest TikTok narrative treats gel as categorically inferior to injections. That's too simple. Gel fails certain patients not because it's a bad technology but because absorption predictability varies dramatically with body composition, skin condition, and application consistency. What TikTok rarely addresses is that poor gel outcomes are frequently a monitoring failure, not a formulation failure. Clinical guidelines from the Endocrine Society (Wylie et al., 2016, Journal of Clinical Endocrinology and Metabolism) recommend checking serum testosterone levels 2-4 weeks after initiation and at each dose change, with a target peak level of 400-700 ng/dL for most transmasculine patients. Many patients in community discussions report never having levels checked mid-cycle on gel, which makes it impossible to distinguish poor absorption from inadequate dosing. The other missing piece: some creators imply switching delivery methods is straightforward and self-directed. It is not. Dose equivalency between gel and injection is not linear, and transition should involve lab monitoring.

What should you actually know?

If testosterone gel isn't getting your levels where they need to be, that's a real clinical problem with documented causes, not a personal failure. Absorption failure on gel is more common in individuals with higher body fat percentages, those who apply to non-optimal sites, or those who shower or swim within 2 hours of application. A 2019 retrospective analysis by Cocchetti et al. in the Journal of Sexual Medicine found that among trans masculine individuals, roughly 22% required dose escalation or method switching within the first year of gel therapy due to subtherapeutic levels. Injections, particularly testosterone cypionate or enanthate at typical clinical doses, produce reliable supraphysiologic peaks followed by troughs, which is why monitoring timing relative to injection day matters for interpreting labs. If you're considering switching or retrying a delivery method, the decision should be based on actual serum levels drawn at the right time, not symptoms alone. Symptoms of low testosterone overlap with other conditions and aren't sufficient to guide treatment changes without bloodwork.